The characterisation and determinants of quality of life in ANCA associated vasculitis-Reference-Cited by-同舟云学术

The characterisation and determinants of quality of life in ANCA associated vasculitis

Published:2013-01-25 Issue:1 Volume:73 Page:207-211
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Basu Neil,McClean Andrew,Harper Lorraine,Amft Esther Nicole,Dhaun Neeraj,Luqmani Raashid A,Little Mark A,Jayne David RW,Flossmann Oliver,McLaren John,Kumar Vinod,Erwig Lars P,Reid David M,Jones Gareth T,Macfarlane Gary J

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference33 articles.

1. Investigation of quality of life, mood, pain, disability, and disease status in primary systemic vasculitis;Koutantji;Arthritis Rheum-Arthritis Care Res,2003

2. Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis;Basu;Rheumatology,2010

3. Impaired health-related quality of life in patients treated for Wegener's granulomatosis;Faurschou;J Rheumatol,2010

4. Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's);Tomasson;Arthritis Care Res (Hoboken),2012

5. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies;Watts;Ann Rheum Dis,2007

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microscopic polyangiitis, an onset with diffuse alveolar hemorrhage;Salud, Ciencia y Tecnología - Serie de Conferencias;2024-07-12

2. Treatment goals in ANCA-associated vasculitis: defining success in a new era;Frontiers in Immunology;2024-06-13

3. Developing a disease-specific patient reported outcome measure to enhance understanding of the lived experiences of ANCA associated vasculitis: A protocol paper;PLOS ONE;2024-03-07

4. Hydroxychloroquine as a potential therapy for ANCA-associated vasculitis;Vessel Plus;2024-02-28

5. A systematic review of patient-reported outcome measures in patients with anti-neutrophil cytoplasmic antibody associated vasculitis;Rheumatology;2024-02-03